RIZZI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.576
EU - Europa 2.841
AS - Asia 1.331
SA - Sud America 76
AF - Africa 12
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.843
Nazione #
US - Stati Uniti d'America 4.521
IT - Italia 1.056
DE - Germania 516
SG - Singapore 509
CN - Cina 317
IE - Irlanda 266
SE - Svezia 208
HK - Hong Kong 191
RU - Federazione Russa 188
GB - Regno Unito 126
UA - Ucraina 101
ID - Indonesia 99
AT - Austria 94
FI - Finlandia 67
BR - Brasile 65
IN - India 59
VN - Vietnam 59
CA - Canada 53
DK - Danimarca 44
BE - Belgio 36
NL - Olanda 33
FR - Francia 31
TR - Turchia 23
JP - Giappone 19
PL - Polonia 16
CH - Svizzera 15
CZ - Repubblica Ceca 11
KR - Corea 11
ES - Italia 8
IR - Iran 8
RO - Romania 8
TW - Taiwan 6
BG - Bulgaria 5
EE - Estonia 5
EG - Egitto 5
AE - Emirati Arabi Uniti 4
PK - Pakistan 4
AR - Argentina 3
CL - Cile 3
CO - Colombia 3
KG - Kirghizistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SC - Seychelles 3
TH - Thailandia 3
AU - Australia 2
CY - Cipro 2
EC - Ecuador 2
EU - Europa 2
HU - Ungheria 2
IQ - Iraq 2
MA - Marocco 2
MX - Messico 2
PH - Filippine 2
PT - Portogallo 2
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
TN - Tunisia 1
Totale 8.843
Città #
Ann Arbor 1.418
Singapore 374
Frankfurt am Main 367
Chandler 348
Wilmington 306
Milan 303
Fairfield 300
Woodbridge 294
Dublin 237
Ashburn 195
Hong Kong 190
Dearborn 139
Seattle 131
Houston 125
New York 114
Santa Clara 104
Cambridge 97
Jakarta 97
Princeton 86
Vienna 85
Jacksonville 83
Nanjing 53
Rome 51
Helsinki 48
Shanghai 42
Brussels 35
Council Bluffs 34
Altamura 33
London 31
Lawrence 30
Pune 29
Guangzhou 27
Nuremberg 22
Fremont 21
Sligo 21
San Diego 20
Bari 18
Los Angeles 18
Monza 18
Beijing 17
Hangzhou 17
Dong Ket 16
Romola 16
Shenyang 16
Andover 15
Carate Brianza 15
Nanchang 15
Kunming 14
Lachine 14
Turin 14
Boardman 12
Toronto 12
Hebei 11
Munich 11
Sacramento 11
Falls Church 10
Melzo 10
Norwalk 10
Edmonton 9
Tianjin 9
Tokyo 9
Brno 8
Changsha 8
Como 8
Kiev 8
Padova 8
Brescia 7
Genoa 7
Ottawa 7
Ankara 6
Bergamo 6
Chiavari 6
Chicago 6
Hefei 6
Jinan 6
Pescara 6
Sesto San Giovanni 6
São Paulo 6
Zurich 6
Arcore 5
Bodio Lomnago 5
Bologna 5
Bresso 5
Jiaxing 5
Mountain View 5
Napoli 5
Pavia 5
Storrs 5
Tallinn 5
Tampa 5
Terni 5
Verona 5
Bolzano 4
Bonndorf 4
Bournemouth 4
Cagliari 4
Changchun 4
Cologne 4
Dallas 4
Garbagnate Milanese 4
Totale 6.445
Nome #
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 368
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 354
Growth hormone secretagogues and the regulation of calcium signaling in muscle 330
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 324
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 320
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 295
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 285
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 259
Identificazione di nuove strategie terapeutiche per il controllo dell'obesità e della cachessia mediante utilizzo di nuovi composti peptidomimetici dotati di attività antagonista o agonista dell'ormone peptidico endogeno ghrelin 254
Effect of nutrition on neurodegenerative diseases. A systematic review 248
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 242
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 237
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 222
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 218
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 218
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 214
Neurotrophic and neuroregenerative effects of GH/IGF1 212
Parma consensus statement on metabolic disruptors 207
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 201
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 196
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens 191
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 191
TLQP-21 modulate inflammation and fibrosis in a model of ards 188
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 186
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 180
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 170
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 158
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 155
Androgen therapy in neurodegenerative diseases 150
Agreement and tense as distinctive syntactic positions. Evidence from acquisition 147
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 145
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 139
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 139
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 138
The role of nutrition on Parkinson’s disease: a systematic review 137
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 137
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 130
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 121
The role of androgens in women's health and wellbeing 115
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 110
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 101
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 97
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 82
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 77
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 77
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 73
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 69
Resolvin E1 and Cytokines Environment in Skeletally Immature and Adult ACL Tears 68
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 62
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results 57
null 57
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 57
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 40
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 33
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 32
Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction 25
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 23
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 19
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 18
Role of nutrition in degenerative disease 6
Totale 9.304
Categoria #
all - tutte 32.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 0 0 0 0 0 105 77 32
2020/20211.537 61 54 141 147 123 155 128 154 142 137 140 155
2021/2022889 116 96 82 84 49 58 41 31 25 90 70 147
2022/20231.542 160 359 181 145 85 232 27 105 101 29 54 64
2023/20241.151 34 67 83 82 124 246 193 67 70 59 26 100
2024/20251.789 152 222 203 187 227 202 242 152 191 11 0 0
Totale 9.304